Y 451.56 Alleghany Corp $Y Hit a 52 week high of 451.56

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
Y 451.56 Alleghany Corp $Y Hit a 52 week high of 451.56 Currently at 451.56 +1.57 +0.35% With a day low of 449.11 and a total volume of 735.

Y Alleghany Corp Recent Headline News

Alleghany Q3 Earnings Beat on Solid Underwriting Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:20AM CST
Alleghany Corporation (Y) reported net earnings of $11.40 per share for the third quarter of 2014, outperforming the Zacks Consensus Estimate of $7.82 by 45.8%
RE: 171.24 (-0.26), CB: 101.48 (-0.39), Y: 449.02 (-0.97), WRB: 51.17 (-0.28)

Alleghany posts 3Q profit
Automated Insights - Mon Nov 03, 6:45PM CST
NEW YORK (AP) _ Alleghany Corp. (Y) on Monday reported profit of $186.3 million, or $11.40 per share, in its third quarter.
Y: 449.02 (-0.97)

W.R. Berkley Hits 52-Week High on Strong Q3 Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 3:53PM CST
Shares of W.R. Berkley Corp. (WRB) hits 52-week high on robust third quarter earnings.
AFSI: 50.78 (+0.24), ENH: 57.85 (+0.31), Y: 449.02 (-0.97), WRB: 51.17 (-0.28)

Alleghany beats by $3.80, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:24PM CST

Y: 449.02 (-0.97)

Alleghany Corporation Reports 2014 Third Quarter Results -- Notice
PR Newswire - Mon Nov 03, 3:14PM CST
Alleghany Corporation (NYSE: Y) today reported its financial results for the three and nine months ended September 30, 2014. A complete, full-text news release for Alleghany's 2014 third quarter results is available on Alleghany's website at www.alleghany.com and is also contained in a Current Report on Form 8-K that has been filed with the U.S. Securities and Exchange Commission (the "SEC" and is available on the SEC's website at www.sec.gov. In conjunction with the release, Alleghany has also posted its financial supplement to the company's web-site at www.alleghany.com.
Y: 449.02 (-0.97)

Olshan Recognized as First Tier "Best Law Firm" in New York for Securities and Capital Markets and Real Estate Law by U.S. News-Best Lawyers
PR Newswire - Mon Nov 03, 6:30AM CST
Olshan Frome Wolosky LLP today announced that it has been ranked "Tier 1" in the New York City Metropolitan area for Securities and Capital Markets and Real Estate Law by U.S. News-Best Lawyers® "Best Law Firms" 2015, and has been ranked "Tier 2" Nationally for both the Securities and Capital Markets and Real Estate practices.
JASN: 8.45 (-0.06), Y: 449.02 (-0.97)

Alleghany Capital Corporation Announces Two Acquisitions By Kentucky Trailer
PR Newswire - Tue Oct 28, 8:27AM CDT
Alleghany Capital Corporation ("ACC", a wholly-owned subsidiary of Alleghany Corporation, today announced that its subsidiary, R.C. Tway Company, LLC ("Kentucky Trailer", a leading manufacturer of custom trailers and truck bodies, has acquired Advanced Mobility & Shelter Technologies, LLC ("Advanced Mobility". Advanced Mobility is a designer and builder of custom trailers and specialty vehicles primarily for the mobile medical and television broadcast markets. In a separate transaction, Kentucky Trailer also acquired a complementary specialty vehicle field service operation.
Y: 449.02 (-0.97)

W.R. Berkley Beats Earnings, Revenues on High Premiums - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:30AM CDT
W.R. Berkley Corporation (WRB) reported third-quarter 2014 operating income of $1.06 per share, outperforming the Zacks Consensus Estimate by 16.5%
AFSI: 50.78 (+0.24), Y: 449.02 (-0.97), AWH: 37.23 (-0.56), WRB: 51.17 (-0.28)

Chubb Beats Q3 Earnings on Low CAT Loss; Raises Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:20AM CDT
The Chubb Corporation (CB) reported third-quarter operating income of $2.17 per share, which surpassed the Zacks Consensus Estimate by 11.3% and improved 5% year over year.
AFSI: 50.78 (+0.24), CB: 101.48 (-0.39), Y: 449.02 (-0.97), AWH: 37.23 (-0.56)

Everest Re Q3 Earnings Beat Estimates, Top Line Grows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:00AM CDT
Everest Re (RE) posts solid third quarter results, revenues grow.
RE: 171.24 (-0.26), AFSI: 50.78 (+0.24), Y: 449.02 (-0.97), AWH: 37.23 (-0.56)

AmTrust Financial Hits 52-Week High on Positive Tidings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 12:30PM CDT
On Oct 21, 2014, AmTrust Financial Services, Inc. (AFSI) scaled a 52-week high of $50.00 on the back of a series of positive tidings.
AFSI: 50.78 (+0.24), ENH: 57.85 (+0.31), Y: 449.02 (-0.97), TRV: 102.93 (-0.06)

Apogee, Actuant, Allied World Assurance,Alleghany andHCI Group highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Oct 22, 8:30AM CDT
Zacks Equity Research highlights Apogee (Nasdaq:APOG-Free Report) as the Bull of the Day and Actuant (NYSE:ATU-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAllied World Assurance Company Holdings, AG (NYSE:AWH-Free Report), Alleghany Corp. (NYSE:Y-Free Report) and HCI Group, Inc. (NYSE:HCI-Free Report).
Y: 449.02 (-0.97)

Is Allied World (AWH) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 5:15PM CDT
On Oct 21, 2014, Zacks Investment Research upgraded Allied World Assurance Company Holdings, AG (AWH) to a Zacks Rank #1 (Strong Buy).
HCI: 43.96 (+0.05), ENH: 57.85 (+0.31), Y: 449.02 (-0.97), AWH: 37.23 (-0.56)

Atlas Financial Inks Global Liberty Deal to Boost Position - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 6:15PM CDT
Atlas Financial Holdings, Inc. (AFH) has inked a deal to acquire Global Liberty Insurance Company and its affiliated underwriting and premium finance companies.
RLI: 49.10 (-0.33), ENH: 57.85 (+0.31), Y: 449.02 (-0.97)

Atlas Financial Holdings (AFH) Rises: Stock Up 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:04AM CDT
Atlas Financial Holdings, Inc. (AFH) was a big mover last session, as the company saw its shares rise over 7% on the day.
HCI: 43.96 (+0.05), AFH: 14.47 (+0.24), ENH: 57.85 (+0.31), Y: 449.02 (-0.97)

RLI Corp Q3 Earnings Beat, Down Y/Y on Higher Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:10AM CDT
RLI Corp.'s (RLI) third-quarter operating earnings of 68 cents per share beat the Zacks Consensus Estimate by 13% but lagged year over year on higher expenses.
AHL: 43.33 (-0.22), RLI: 49.10 (-0.33), ENH: 57.85 (+0.31), Y: 449.02 (-0.97)

Is White Mountains (WTM) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 12:40PM CDT
On Oct 15, 2014, Zacks Investment Research upgraded White Mountains Insurance Group, Ltd. (WTM) to a Zacks Rank #1 (Strong Buy).
AHL: 43.33 (-0.22), WTM: 634.91 (+1.59), Y: 449.02 (-0.97), OB: 16.50 (+0.01)

ProAssurance's Acquisitions, Capital Activity Look Good - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 12:10PM CDT
On Oct 10, 2014, we issued an updated research report on ProAssurance Corporation (PRA).
AHL: 43.33 (-0.22), AGII: 55.56 (-0.08), PRA: 44.98 (-0.16), Y: 449.02 (-0.97)

Donegal Group (DGICA) Gains on A.M. Best's Rating Action - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 6:00PM CDT
Shares of Donegal Group Inc. (DGICA) increased 1.4% over the last trading session to close at $15.79 after affirmation of the company's ratings by A. M. Best Company.
AHL: 43.33 (-0.22), AFSI: 50.78 (+0.24), DGICA: 15.11 (-0.43), Y: 449.02 (-0.97)

Should AmTrust Financial (AFSI) be in Your Portfolio Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 1:40PM CDT
On Oct 9, Zacks Investment Research upgraded AmTrust Financial Services, Inc. (AFSI) to a Zacks Rank #1 (Strong Buy).
AHL: 43.33 (-0.22), AGII: 55.56 (-0.08), AFSI: 50.78 (+0.24), Y: 449.02 (-0.97)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading